We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 164.20
Bid: 163.60
Ask: 166.20
Change: 1.80 (1.11%)
Spread: 2.60 (1.589%)
Open: 162.00
High: 164.40
Low: 162.00
Prev. Close: 162.40
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Oct 2023 07:00

RNS Number : 5905Q
Sabre Insurance Group PLC
19 October 2023
 

19 October 2023

Sabre Insurance Group plc

 

Trading Update

Strong premium growth and healthy capital position

 

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 July 2023 to 30 September 2023.

Financial highlights

Nine months ended

30 September

Year ended

31 December

 2023

2022

% change

2022

Gross written premium

£162.2m

£135.7m

19.5%

£171.3m

Gross written premium - Motor Vehicle

£140.5m

£105.2m

33.6%

£134.9m

Gross written premium - Motorcycle

£10.7m

£20.9m

(48.8%)

£23.1m

Gross written premium - Taxi

£11.0m

£9.6m

14.6%

£13.3m

Post-dividend solvency capital ratio

191%

163%

154%

Business highlights for the first nine months of 2023

? Strong performance from our core Motor Vehicle book

? Gross written premiums ('GWP') up 34% year-to-date and up 61% versus Q3 2022

? In recent weeks, premium run-rate has been over 80% up year-on-year

? Increase in policy count, while maintaining continued focus on profitability as a target and volume as an output. Core Motor Vehicle policy count 222k at 30 September 2023 (30 June 2023: 211k)

? Significant rate increases mitigating the impact of claims inflation and ensuring margins return towards historical levels for business written in recent months

? Increase in solvency capital ratio reflects return towards historical levels of underwriting profitability on core Motor Vehicle business and profitable growth

? Good performance from Motorcycle book

? Ongoing focus on margin over volume - with rate increases expected to drive improved loss ratio performance for 2023 vs 2022

? Policy count and premium growth impacted by the cessation of trading with MCE Insurance, offset by increase in sales through our alternate channel. Motorcycle policy count 45k at 30 September 2023 (30 June 2023: 48k)

? Taxi book performance improving as planned

? Taxi market remains challenging, significant underwriting actions starting to show improved loss ratio performance but have reduced premium run-rate vs 2022. Taxi policy count 13k at 30 September 2023 (30 June 2023: 14k)

? Underwriting performance across the portfolio in Q3 supports expectation of an improvement in the combined operating ratio for H2 vs H1 2023. Expect combined operating ratio for 2023 at the higher end of 85% - 90% on a discounted basis in-line with previous guidance

? Post-dividend solvency capital ratio as at 30 September 2023 of 191% (30 September 2022: 163%)

? Expect to have sufficient capital to allow the Board flexibility in determining an appropriate dividend distribution at year-end in-line with our policy - an ordinary dividend payout ratio of 70% of adjusted profit after tax and a distribution of surplus capital through special dividends

Market trends

? Growth in our GWP and policy count despite price increases suggests market pricing correction has continued through Q3, with Sabre continuing to see the benefits of acting early with respect to pricing

? Claims inflation for 2023 continues at around 10%, however rate increases applied are sufficient to cover slightly higher levels of inflation and improve loss ratios towards historical norms, from which we expect to see the benefit in 2024

Full-year premium guidance raised; profitability reaffirmed

? Premium in recent months has been above expectations, therefore we increase our overall 2023 full-year gross written premium year-on-year growth expectation to 20% - 25%

? Reiterate profitability guidance provided at half-year, expect discounted combined operating ratio for the full-year 2023 at the upper end of the 85% - 90% range

? Premium growth and momentum in underwriting margin improvements will earn through in 2024, which we expect to result in further improvement in combined operating ratio in-line with previous guidance

Geoff Carter, Chief Executive Officer of Sabre, commented:

"Having stuck firmly to our 'profitability over volume' strategy through four-years of persistent market under-pricing and periods of very high inflation, we are now starting to show the benefits of our strategy as market pricing continues to correct.

We have been able to increase prices at a level to cover high on-going inflation whilst also returning anticipated profitability on written business towards our historical levels - in recent months core Motor Vehicle business has been written at an assessed sub-80% undiscounted combined operating ratio - which we have achieved at the same time as writing total GWP considerably higher than our expectations. This should contribute to continued improvement in the financial-year combined operating ratio for 2024, as business written in recent months starts to earn through and the impact of Taxi business written earlier in 2023 subsides.

It is also pleasing to see Motorcycle now performing at around the required level and Taxi performance improving as planned.

Our success so far this year is evident in the high premium levels and very strong solvency position which will allow sufficient headroom for further growth whilst allowing the Board flexibility in determining an appropriate dividend distribution at year-end in-line with our policy.

I would like to thank all our people and shareholders, who have supported Sabre through an extended and challenging market, as we look to a bright and exciting future."

Investor enquiries

01306 747 272

Sabre Insurance Group plc

investor.relations@sabre.co.uk

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White / Eleanor Pomeroy

LEI Code: 2138006RXRQ8P8VKGV98

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFWFWAEDSEDS
Date   Source Headline
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
13th Jun 202310:09 amRNSDirector/PDMR Shareholding
2nd Jun 20233:02 pmRNSDirector/PDMR Shareholding
25th May 202311:22 amRNSResult of AGM
25th May 20239:27 amRNSDirector/PDMR Shareholding
25th May 20237:01 amRNSBoard Appointment
25th May 20237:00 amRNSTrading Update
11th May 202311:42 amRNSDirector/PDMR Shareholding
18th Apr 20233:19 pmRNSDirector/PDMR Shareholding
12th Apr 202311:53 amRNSDirector/PDMR Shareholding
6th Apr 202312:28 pmRNSDirector/PDMR Shareholding
31st Mar 20233:43 pmRNSNotice of AGM
31st Mar 20233:37 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
13th Mar 202312:13 pmRNSDirector/PDMR Shareholding
13th Feb 20231:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.